Office
100 Medical Plz Suite 310, Los Angeles, CA 90095
(310) 825-7922
Internal medicine in Santa Monica, CA · The Regents of the University of California
No reviews yet. Be the first to review
100 Medical Plz Suite 310, Los Angeles, CA 90095
(310) 825-7922
89.3 out of 100 in Medicare’s Merit-based Incentive Payment System for 2024 (practice group score). Medicare Care Compare
In 2025, drug and medical-device companies reported $56,339 in general payments to Alexandra Drakaki (31 payments). Largest: AstraZeneca Pharmaceuticals LP ($21,487); Astellas Pharma Global Development ($18,756); AstraZeneca UK Limited ($8,200). Reported under the federal Open Payments program.
Billed services and units in Original Medicare Part B, 2024.
Scroll the table sideways to see every column.
| HCPCS | Billed services / units | Beneficiaries in this row | Service description (English) | Billing setting |
|---|---|---|---|---|
| 80053 | 411 | 143 | Blood test, comprehensive group of blood chemicals | Non-facility |
| 82378 | 15 | 12 | Carcinoembryonic antigen (cea) protein level | Non-facility |
| 82607 | 18 | 14 | Cyanocobalamin (vitamin b-12) level | Non-facility |
| 83615 | 85 | 30 | Lactate dehydrogenase (enzyme) level | Non-facility |
| 83735 | 79 | 25 | Magnesium level | Non-facility |
| 84100 | 53 | 20 | Phosphate level | Non-facility |
| 84550 | 30 | 11 | Uric acid level, blood | Non-facility |
| 85025 | 431 | 151 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Non-facility |
| 86301 | 25 | 20 | Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 | Non-facility |
| 96361 | 85 | 22 | Infusion into a vein for hydration, each additional hour | Non-facility |
| 96365 | 20 | 18 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Non-facility |
| 96366 | 31 | 17 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Non-facility |
| 96367 | 116 | 28 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Non-facility |
| 96372 | 37 | 23 | Injection of drug or substance under skin or into muscle | Non-facility |
| 96375 | 188 | 29 | Injection of additional new drug or substance into vein | Non-facility |
Scroll the table sideways to see every column.
| HCPCS | Billed services / units | Beneficiaries in this row | Service description (English) | Billing setting |
|---|---|---|---|---|
| 96402 | 50 | 25 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Non-facility |
| 96413 | 265 | 54 | Administration of chemotherapy into vein, 1 hour or less | Non-facility |
| 96415 | 19 | 12 | Administration of chemotherapy into vein, each additional hour | Non-facility |
| 96417 | 75 | 24 | Administration of additional new drug or substance into vein, 1 hour or less | Non-facility |
| 99205 | 18 | 18 | New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | Non-facility |
| 99214 | 53 | 44 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Non-facility |
| 99215 | 1,046 | 197 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | Non-facility |
| G2211 | 217 | 130 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Non-facility |
Drug units follow each billing code’s definition.
Scroll the table sideways to see every column.
| HCPCS | Drug billing units | Beneficiaries in this row | Service description (English) | Billing setting |
|---|---|---|---|---|
| J0897 | 2,040 | 12 | Injection, denosumab, 1 mg | Non-facility |
| J1100 | 644 | 21 | Injection, dexamethasone sodium phosphate, 1 mg | Non-facility |
| J1200 | 38 | 12 | Injection, diphenhydramine hcl, up to 50 mg | Non-facility |
| J1453 | 4,650 | 12 | Injection, fosaprepitant, 1 mg | Non-facility |
| J2405 | 952 | 16 | Injection, ondansetron hydrochloride, per 1 mg | Non-facility |
| J2469 | 190 | 12 | Injection, palonosetron hcl, 25 mcg | Non-facility |
| J3475 | 208 | 17 | Injection, magnesium sulfate, per 500 mg | Non-facility |
| J7030 | 52 | 17 | Infusion, normal saline solution , 1000 cc | Non-facility |
| J7040 | 84 | 21 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Non-facility |
| J7050 | 315 | 42 | Infusion, normal saline solution, 250 cc | Non-facility |
| J9217 | 232 | 26 | Leuprolide acetate (for depot suspension), 7.5 mg | Non-facility |
| J9271 | 18,901 | 17 | Injection, pembrolizumab, 1 mg | Non-facility |
The office is at 100 Medical Plz Suite 310, Los Angeles, CA 90095.
The office phone is (310) 825-7922.
Specialty: Internal medicine.
Yes. Alexandra Drakaki billed Original Medicare Part B services in 2024 (see Medicare activity above).
Alexandra Drakaki's NPI is 1992972897.
Alexandra Drakaki is affiliated with Ronald Reagan UCLA Medical Center (Los Angeles, CA); Santa Monica - UCLA Med Ctr & Orthopaedic Hospital (Santa Monica, CA).
Yes. Alexandra Drakaki offers telehealth visits.
All reviews are moderated. Review policy